Pune's Gennova gets nod for clinical trials of India's first mRNA vaccine

DCGI granted conditional approval for phase 1 and 2 clinical trials of Gennova's mRNA based Covid-19 vaccine candidate

Pune based firm Gennova Biopharmaceuticals Ltd has been granted permission for phase 1 and 2 human clinical trials for the Covid-19 vaccine candidate developed by them. This would be the first Indian mRNA vaccine candidate.

The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the Covid-19 vaccine developed by them. The Subject Expert Committee (SEC) deliberated on their proposal and granted permission to conduct phase 1 and 2 trials along with animal toxicity study data. DCGI has approved the same.

Meeting minutes of the SEC noted that, "After detailed deliberation,